reports
Philips and Cortechs.ai extend partnership to advance quantitative neu...
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology November 19, 2025Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership with , a pioneer in quantitative neuroimaging solutions. Together, the companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems [1], empowering clinicians with faster, more objective, and reproducible insights into brain health. The col...
- Marc Hesselink
- CFA
- Thymen Rundberg
Philips/Something better, something worse/HOLD
Philips reported a better-than-expected 3Q25 update although with mixed underlying quality. We have limited changes to estimates and reiterate our €23/share target price and Hold rating. We believe valuation is fair relative to peers given Philips' lower growth and margin profile.
Philips brings AI into the procedure room to assist doctors during hea...
Philips brings AI into the procedure room to assist doctors during heart valve repair November 17, 2025Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence**Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one of interventional cardiology’s most technically demanding procedures: repairing leaking heart valves through a minimally invasive appr...
- Colin Smith
Polarean Imaging | Proposed delisting from AIM market
Further to the strategic review announced on 22 October, Polarean has now formally proposed to delist from AIM and take the company private. The reasons cited by Polarean are: stronger access to capital, listing and compliance costs, public market undervaluation, and the current funding environment. Polarean reiterated its cash runway guidance through 2Q26 and its anticipated US$20m funding requirement. Cancellation from AIM is subject to a special resolution requiring a 75% vote in favour of th...
Thermo Fisher Scientific Inc: 2 directors
Two Directors at Thermo Fisher Scientific Inc sold after exercising options/sold 5,696 shares at between 588.265USD and 594.420USD. The significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tra...
- Oliver Metzger
- Thomas Zlowodzki
- Wim Gille
FME FRESENIUS MEDICAL CARE AG
EDEN EDENRED SA
DBK DEUTSCHE BANK AG
ULVR UNILEVER PLC
MMK MAYR-MELNHOF KARTON AG
PHIA KONINKLIJKE PHILIPS N.V.
GEBN GEBERIT AG
NXT NEXT PLC
RY4C RYANAIR HOLDINGS PLC
NEM NEMETSCHEK SE
ARCAD ARCADIS NV
EVK EVONIK INDUSTRIES AG
COLO B COLOPLAST A/S CLASS B
SNP PETROM S.A.
BP. BP P.L.C.
BIM BIOMERIEUX SA
TEF TELEFONICA SA
BNTX BIONTECH SE
AMRZ AMRIZE AG
AAL ANGLO AMERICAN PLC
- Oliver Metzger
- Thomas Zlowodzki
- Wim Gille
FME FRESENIUS MEDICAL CARE AG
EDEN EDENRED SA
DBK DEUTSCHE BANK AG
ULVR UNILEVER PLC
MMK MAYR-MELNHOF KARTON AG
PHIA KONINKLIJKE PHILIPS N.V.
GEBN GEBERIT AG
NXT NEXT PLC
RY4C RYANAIR HOLDINGS PLC
NEM NEMETSCHEK SE
ARCAD ARCADIS NV
EVK EVONIK INDUSTRIES AG
COLO B COLOPLAST A/S CLASS B
SNP PETROM S.A.
BP. BP P.L.C.
BIM BIOMERIEUX SA
TEF TELEFONICA SA
BNTX BIONTECH SE
AMRZ AMRIZE AG
AAL ANGLO AMERICAN PLC
- Oscar Rodriguez
- Oliver Metzger
- Wim Gille
- Research Department
INFORME DIARIO 04 NOVIEMBRE + RDOS. ESPAÑA Y EUROPA 3T’25. IDEAS DESTA...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: TELEFÓNICA. EUROPA: AIRBUS, PHILIPS. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’25 que se publicarán en España y Europa en los próximos días. Sesión de más a menos ayer y de caídas hoy Comenzó en Europa el mes de noviembre con subidas que fueron diluyéndose en una jornada donde las miradas siguieron ...
- ING Helpdesk
Benelux Morning Notes
Azelis: Appointment of Boris Cambon-Lalanne as group CFO. Belgian Telecoms: Price increase on most of the non-commercialised products and Scarlet trio. D'Ieteren: Belgian October car registrations down 7%, VW down 20%. Kendrion: Results preview; launching share buyback programme. Kinepolis: Acquires US movie theatre chain Emagine Entertainment for US$105m. Kinepolis: October box office in US/Canada and France attendance drop again. Ontex: Branded activity now fully divested. Philip...
Philips continues momentum; delivers strong order intake, step-up in s...
Philips continues momentum; delivers strong order intake, step-up in sales growth and margin expansion November 4, 2025Q3 2025 Group Highlights Comparable order intake growth 8%Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable salesIncome from operations was EUR 330 millionAdjusted EBITA margin increased by 50 basis points to 12.3% of salesOperating cash flow of EUR 327 million, with a free cash flow of EUR 172 millionPhilips reiterates full-year 2025 outlook, with margin now expected at the upper end of the range Roy Jakobs, CEO of Royal Philips:“In this quart...
Kromek Group: 1 director
A director at Kromek Group maiden bought 285,000 shares at 6.7p and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Hoag selects Philips to enhance and unify patient monitoring, elevatin...
Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA October 30, 2025 10-year collaboration aims to connect scalable monitoring technology that streamlines workflows, supporting patient safety and the patient and clinician experienceAmsterdam, the Netherlands and Newport Beach, Calif., USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and , Orange County, California’s highest-ranked hospital, today announced a landmark 10-year strategic collaboration. The initiative will standardize and modernize patient monitoring across...
Moody's Ratings says Thermo Fisher's Clario acquisition expands clinic...
Moody's Ratings commented that Thermo Fisher Scientific Inc.'s (A3 positive) announcement that it entered into a definitive agreement to acquire privately held Clario Holdings, Inc. for $8.88 billion plus certain potential future payouts will add scale and earnings diversity and bolster capabilities...
- Margaux van Oerle
- Oliver Metzger
- Wim Gille
DB1 DEUTSCHE BOERSE AG
BN DANONE SA
BNP BNP PARIBAS SA CLASS A
ADS ADIDAS AG
FORTUM FORTUM OYJ
DAI DAIMLER AG
OMV OMV AG
AMUN AMUNDI SA
PHIA KONINKLIJKE PHILIPS N.V.
ELE ENDESA S.A.
NXT NEXT PLC
BAS BASF SE
CAP CAPGEMINI SE
SY1 SYMRISE AG
SPL SANTANDER BANK POLSKA SA
ASM ASM INTERNATIONAL N.V.
MONC MONCLER SPA
IBE IBERDROLA SA
SNP PETROM S.A.
STM STMICROELECTRONICS NV
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
ADYEN ADYEN NV
8TRA TRATON SE
STMN STRAUMANN HOLDING AG
FER FERROVIAL SA
AENA AENA S.M.E. SA
TKMS TKMS AG & CO. KGAA
- Margaux van Oerle
- Oliver Metzger
- Wim Gille
DB1 DEUTSCHE BOERSE AG
BN DANONE SA
BNP BNP PARIBAS SA CLASS A
ADS ADIDAS AG
FORTUM FORTUM OYJ
DAI DAIMLER AG
OMV OMV AG
AMUN AMUNDI SA
PHIA KONINKLIJKE PHILIPS N.V.
ELE ENDESA S.A.
NXT NEXT PLC
BAS BASF SE
CAP CAPGEMINI SE
SY1 SYMRISE AG
SPL SANTANDER BANK POLSKA SA
ASM ASM INTERNATIONAL N.V.
MONC MONCLER SPA
IBE IBERDROLA SA
SNP PETROM S.A.
STM STMICROELECTRONICS NV
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
ADYEN ADYEN NV
8TRA TRATON SE
STMN STRAUMANN HOLDING AG
GSK GSK PLC
FER FERROVIAL SA
AENA AENA S.M.E. SA
TKMS TKMS AG & CO. KGAA
Late-breaking iMODERN findings presented at TCT 2025 and published in ...
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant difference in major outcomes compared with waiting for follow-upAdditional results from the ILIAS ANOCA study highlight the sustained benefits of physiology-guided assessment and tailored medical therapy for patients...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.